Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 10-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 66)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
9-Feb-10 New Constructs, LLC N/A COV: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Health Care Technologies Overview 2010 (Summary) 80 $199 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Market Research and Competitive Analysis 2010 730 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Trends, Statistics & Analysis 2010 (Summary) 98 $199 View Abstract
8-Feb-10 Market Edge N/A Market Edge Equity Research Report 4 $10 View Abstract
7-Feb-10 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (Global) 144 $169 View Abstract
7-Feb-10 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (North America) 100 $169 View Abstract
7-Feb-10 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (United States) 98 $169 View Abstract
Next 20

Brokerage Reports (Showing 1 to 10 of 11)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
29-Jan-10 Morgan Keegan & Company, Inc. N/A First Look - Jan 29 2010 08:00AM 12 $25 View Abstract
29-Jan-10 Morgan Keegan & Company, Inc. Lawrence S. Keusch BAX: Attractive valuation with solid business fundamentals and R&D optionality 12 $25 View Abstract
28-Jan-10 Morgan Keegan & Company, Inc. N/A First Look - Jan 28 2010 08:00AM 10 $25 View Abstract
27-Jan-10 Morgan Keegan & Company, Inc. Lawrence S. Keusch No impact to BCR, BDX, and COV from FDA recall of Nipro needles 4 $10 View Abstract
21-Jan-10 Morgan Keegan & Company, Inc. N/A First Look - Jan 21 2010 08:02AM 13 $50 View Abstract
21-Jan-10 Morgan Keegan & Company, Inc. Lawrence S. Keusch COV: Little to critique on the 1Q with strong margins and execution 11 $25 View Abstract
20-Jan-10 Thomson StreetEvents N/A COV - Event Transcript of Covidien Plc. conference call, Jan. 20, 2010 / 8:30am ET 20 $75 View Abstract
20-Jan-10 Thomson StreetEvents N/A COV - Event Brief of Covidien Plc. conference call, Jan. 20, 2010 / 8:30am ET 21 $75 View Abstract
19-Jan-10 Morgan Keegan & Company, Inc. N/A First Look - Jan 19 2010 08:03AM 6 $25 View Abstract
19-Jan-10 Morgan Keegan & Company, Inc. Lawrence S. Keusch Medical devices: 4Q earnings expected to be solid on the heels of FX 7 $25 View Abstract
Next 1

Independent Reports (Showing 1 to 10 of 55)

Release
Date Contributor Author Title Pages Price More Info
9-Feb-10 New Constructs, LLC N/A COV: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Health Care Technologies Overview 2010 (Summary) 80 $199 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Market Research and Competitive Analysis 2010 730 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Trends, Statistics & Analysis 2010 (Summary) 98 $199 View Abstract
8-Feb-10 Market Edge N/A Market Edge Equity Research Report 4 $10 View Abstract
7-Feb-10 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (Global) 144 $169 View Abstract
7-Feb-10 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (North America) 100 $169 View Abstract
7-Feb-10 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (United States) 98 $169 View Abstract
Next 20

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.